NRIX: nurixtx.com Net earnings per share for the last 12 months

Symbol and logo of brand Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics (NRIX) TTM net income per share reflects earnings dynamics, where the 2.30 mark records this metric. The cash flow relies on payments from pharma partners and grants for the development of protein degradation systems. Scientific parity with competitors is maintained through unique data that attracts strategic allies. High industry confidence solidifies the brand's status as an innovative leader.

NRIX (Nurix Therapeutics) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/17/2026

Analytical breakdowns for Nurix Therapeutics

Basic company analysis:Nurix Therapeutics - NRIX
Manufactured products of Nurix Therapeutics Inc

Assessing the investment reliability of assets begins with analyzing the issuer's ability to generate real earnings per common share. The net income per share over the last 12 months reflects the final financial result after deducting all expenses, including the high costs incurred by Nurix Therapeutics (NRIX) to retain an elite R&D staff, which allows for the determination of the efficiency of the company's intellectual potential capitalization.

Who Nurix Therapeutics competes with

GMAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year EXEL (Exelixis Corp)|NUVL (Nuvalent) - Net earnings per share for the last 12 months|KYMR: Earnings per share for the last four quarters|IDYA (IDEAYA Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) enliventherapeutics.com|Earnings per share for the last twelve months ORIC Pharmaceuticals, Inc. (ORIC)|RLAY (Relay Therapeutics, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) TYRA (Tyra Biosciences Inc)|Net earnings per share for the trailing year Verastem Inc|Monte Rosa Therapeutics Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cullinan Therapeutics, Inc.|IMRX (Immuneering Corporation) - Net earnings per share for the last 12 months|CCCC: Earnings per share for the last four quarters|BDTX (blackdiamondtherapeutics.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Repare Rx RPTX|Net earnings per share (EPS TTM) PMVP|Karyopharm - Earnings per share for the last 12 months|Propanc Biopharma Inc - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGMS|AADI: Net earnings per share for the last 12 months|aileronrx.com - Earnings per share for the last four quarters|BPMC: Net earnings per share (EPS TTM)|GlycoMimetics Inc. - Earnings per share for the trailing year|SWTX (SpringWorks Therapeutics, Inc) - Net earnings per share (EPS TTM)